Clariant AG (CLRN) Stock Price & Analysis
CLRN Stock Chart & Stats
- Day’s Range
- EUR 10.96 - EUR 11.40
- 52-Week Range
- EUR 7.19 - EUR 11.70
- Previous Close
- EUR 11.47
- Volume
- 50
- Average Volume (3M)
- 206
- Market Cap
- EUR 3.63B
- Enterprise Value
- EUR 3.99B
- Total Cash (Recent Filing)
- EUR 634.40M
- Total Debt (Recent Filing)
- EUR 2.13B
- Price to Earnings (P/E)
- ―
- Beta
- 0.55
- Next Earnings
- Nov 03, 2026 (Est.)
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 3.97%
Bulls Say, Bears Say
Bulls Say
Differentiated Specialty Chemicals Model
Clariant’s specialty products and technical support can create customer value beyond basic chemical volume, supporting differentiated pricing and longer relationships. This business model may help defend margins and sustain demand across plastics, coatings, catalysts and formulated applications over coming quarters.
Growth In Care Chemicals And Additives
Growth in two businesses, including stronger Care Chemicals profitability and higher Adsorbents & Additives volumes, provides a meaningful counterweight to weaker areas. Continued expansion in these applications can support mix quality, utilization and earnings resilience over the next several quarters.
Improving Cash Conversion And Cost Savings
Improved cash conversion and delivered performance savings strengthen internal funding capacity while management continues restructuring and efficiency actions. If sustained, these measures can support liquidity, partially offset weaker earnings, and provide a clearer path toward the targeted 2026–2027 savings run rate.
Bears Say
Persistent Revenue Decline And Net Loss
A multi-year revenue decline combined with a renewed net loss indicates that the company has not yet restored consistent demand and earnings quality. Even with mid-teen EBITDA margins, continued top-line weakness can limit operating leverage, reduce reinvestment capacity and pressure shareholder returns.
Catalysts Business Deterioration
The sharp Catalysts contraction is material because it affects both volume and profitability, while management’s full-year outlook assumes recovery. Delayed orders and lower segment earnings could persist into the next several months, making group results more dependent on recovery that is not yet demonstrated.
Higher Leverage And Reduced Flexibility
Higher net debt relative to EBITDA reduces financial flexibility just as revenue and earnings remain under pressure. Greater leverage can constrain capital allocation, leave less room to absorb operating volatility, and increase dependence on successful cash generation and cost actions to stabilize the balance sheet.
Clariant AG News
CLRN FAQ
What was Clariant AG’s price range in the past 12 months?
What is Clariant AG’s market cap?
When is Clariant AG’s upcoming earnings report date?
How were Clariant AG’s earnings last quarter?
Is Clariant AG overvalued?
Does Clariant AG pay dividends?
What is Clariant AG’s EPS estimate?
How many shares outstanding does Clariant AG have?
What happened to Clariant AG’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Clariant AG?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Clariant AG
Clariant AG operates as a global leader in specialty chemicals, organized into three primary business units: Care Chemicals, Catalysis, and Natural Resources. The company develops and supplies a broad spectrum of chemical products and solutions. This includes fire retardants, performance-enhancing additives, and advanced surface treatments for applications spanning plastics, coatings, inks, and consumer goods. It also provides essential catalysts for petrochemical and fuel refining, synthesis gas, general chemical processes, and emissions control, along with specialized zeolite and custom catalyst solutions. Clariant further manufactures specialized bentonite-based products, serving diverse sectors such as oil purification, foundries, animal feed, civil construction, wastewater treatment, and various industrial uses including paper, detergents, and PVC stabilization. Its extensive portfolio also features industrial and consumer specialty chemicals and tailored application solutions across numerous markets. These encompass automotive fluids (like brake fluids and coolants), aircraft de-icing, construction chemicals, agrochemicals, food ingredients, gas processing, heat transfer, home and industrial cleaning, lubricant additives, specialized solvents, paints and coatings, healthcare, and personal care ingredients. Additionally, the company offers sophisticated oilfield production chemicals for enhanced oil recovery, offshore and unconventional drilling, paraffin control, and well services, complemented by its intelligent chemical management system, Veritrax. Clariant also provides comprehensive chemical solutions for the mining industry, additives for refinery services, and develops biofuels and their derivatives, exemplified by sunliquid, which transforms agricultural residues into cellulosic ethanol. Its product range extends to organic, inorganic, and anti-corrosive pigments, as well as pigment preparations, dyes, and specialty materials vital for coatings, plastics, conventional and digital printing, textiles, and personal care applications. Founded in 1886, Clariant AG is headquartered in Muttenz, Switzerland.
- Sector
- Basicmaterials
- Industry
- Chemicals - Specialty
- CEO
- Conrad Keijzer
- Employees
- 10,107
- Website
- www.clariant.com
- Address
- Rothausstrasse 61, Muttenz, BL, 4132, CH
Clariant AG (CLRN) Earnings & Revenues
CLRN Company Deck
CLRN Earnings Call
Earnings Call SentimentNeutral
The call mixed positive operational and cash‑flow improvements (pricing, margin expansion in Q2, improved free cash flow conversion, increased cost savings and a favorable legal ruling) with clear and material headwinds concentrated in the Catalysts business and group‑level volume, currency and inflationary pressures. Management maintained guidance and outlined actions to offset disruption, but Middle East uncertainty, restructuring costs and higher leverage remain key risks.
View all DE:CLRN earnings summariesCLRN Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 5 | 8 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 5 | 0 | 7 |
